Literature DB >> 26727901

Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.

Chi Hyun Kim1, Hee Young Kang1, Bo Ra Kim1, Hyejin Jeon1, Yoo Chul Lee1, Sang Hwa Lee2, Je Chul Lee3.   

Abstract

This study investigated the mechanisms underlying the carbapenem resistance of bloodstream isolates of Pseudomonas aeruginosa obtained from two Korean hospitals. Of the 79 P. aeruginosa isolates, 22 and 21 were resistant to imipenem and meropenem, respectively. The 22 imipenem-resistant P. aeruginosa isolates were classified into 7 sequence types (STs) and 13 pulsotypes. Twelve imipenem-resistant isolates from one hospital were found to belong to the international clone ST111. Two imipenem-resistant P. aeruginosa ST235 isolates carried the bla IMP-6 gene, but the remaining 20 isolates did not produce carbapenemases. Mutations in the oprD gene and a related decrease in gene expression were found in 21 and 5 isolates, respectively. However, all imipenemresistant P. aeruginosa isolates showed no significant expression of OprD in the outer membrane as compared with that of carbapenem-susceptible PAO1 strain. Overexpression of genes associated with efflux pumps, including mexB, mexD, mexF, and mexY, was not found in any imipenem-resistant isolate. One imipenem-resistant P. aeruginosa isolate overexpressed the ampC gene. Our results show that the low permeability of drugs due to the mutational inactivation of OprD is primarily responsible for carbapenem resistance in bloodstream isolates of P. aeruginosa from Korean hospitals.

Entities:  

Keywords:  OprD protein; carbapenem; efflux pump; international clone; sequence type

Mesh:

Substances:

Year:  2016        PMID: 26727901     DOI: 10.1007/s12275-016-5562-5

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  22 in total

1.  Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification.

Authors:  John S Esterly; Jamie Wagner; Milena M McLaughlin; Michael J Postelnick; Chao Qi; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2012-07-09       Impact factor: 5.191

2.  Rapidec Carba NP Test for Rapid Detection of Carbapenemase Producers.

Authors:  Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2015-06-17       Impact factor: 5.948

3.  Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.

Authors:  John Quale; Simona Bratu; Jyoti Gupta; David Landman
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 4.  Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.

Authors:  Anaïs Potron; Laurent Poirel; Patrice Nordmann
Journal:  Int J Antimicrob Agents       Date:  2015-03-24       Impact factor: 5.283

5.  Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.

Authors:  Gabriel Cabot; Alain A Ocampo-Sosa; Fe Tubau; María D Macia; Cristina Rodríguez; Bartolomé Moya; Laura Zamorano; Cristina Suárez; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

6.  OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.

Authors:  Ji-Young Lee; Kwan Soo Ko
Journal:  Int J Antimicrob Agents       Date:  2012-05-26       Impact factor: 5.283

7.  Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.

Authors:  María García-Castillo; Rosa Del Campo; María Isabel Morosini; Elena Riera; Gabriel Cabot; Rob Willems; Rosa van Mansfeld; Antonio Oliver; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

8.  OprD mutations and inactivation in imipenem-resistant Pseudomonas aeruginosa isolates from China.

Authors:  Zhi-Li Fang; Li-Yan Zhang; Ying-Min Huang; Yun Qing; Kai-Yuan Cao; Guo-Bao Tian; Xi Huang
Journal:  Infect Genet Evol       Date:  2013-11-08       Impact factor: 3.342

Review 9.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

10.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

View more
  7 in total

1.  Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa.

Authors:  Gertrudis Horna; María López; Humberto Guerra; Yolanda Saénz; Joaquim Ruiz
Journal:  Sci Rep       Date:  2018-11-07       Impact factor: 4.379

2.  Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa.

Authors:  Ye Xu; Xiangkuo Zheng; Weiliang Zeng; Tao Chen; Wenli Liao; Jiao Qian; Jie Lin; Cui Zhou; Xuebin Tian; Jianming Cao; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-05-14       Impact factor: 4.003

3.  Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.

Authors:  Michael S Sonnabend; Kristina Klein; Sina Beier; Angel Angelov; Robert Kluj; Christoph Mayer; Caspar Groß; Kathrin Hofmeister; Antonia Beuttner; Matthias Willmann; Silke Peter; Philipp Oberhettinger; Annika Schmidt; Ingo B Autenrieth; Monika Schütz; Erwin Bohn
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

4.  Multilocus sequence typing and variations in the oprD gene of Pseudomonas aeruginosa isolated from a hospital in China.

Authors:  Huiqin Liu; Weina Kong; Weina Yang; Gukui Chen; Haihua Liang; Yani Zhang
Journal:  Infect Drug Resist       Date:  2018-01-08       Impact factor: 4.003

5.  Molecular Typing and Carbapenem Resistance Mechanisms of Pseudomonas aeruginosa Isolated From a Chinese Burn Center From 2011 to 2016.

Authors:  Supeng Yin; Ping Chen; Bo You; Yulong Zhang; Bei Jiang; Guangtao Huang; Zichen Yang; Yu Chen; Jing Chen; Zhiqiang Yuan; Yan Zhao; Ming Li; Fuquan Hu; Yali Gong; Yizhi Peng
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

6.  Exploring the success of Brazilian endemic clone Pseudomonas aeruginosa ST277 and its association with the CRISPR-Cas system type I-C.

Authors:  Melise Chaves Silveira; Cláudio Marcos Rocha-de-Souza; Rodolpho Mattos Albano; Ivson Cassiano de Oliveira Santos; Ana Paula D'Alincourt Carvalho-Assef
Journal:  BMC Genomics       Date:  2020-03-23       Impact factor: 3.969

7.  Analysis of Metallo-β-lactamases, oprD Mutation, and Multidrug Resistance of β-lactam Antibiotic-Resistant Strains of Pseudomonas aeruginosa Isolated from Southern China.

Authors:  Fei Li; Danna Chen; Lijuan Li; Dezhi Liang; Fengping Wang; Bashan Zhang
Journal:  Curr Microbiol       Date:  2020-08-12       Impact factor: 2.188

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.